A Study to Evaluate the Pharmacokinetic Drug-drug Interactions Between VX-548, Midazolam, and Digoxin
Clinical trial NCT05541471 · COMPLETED
Trial details
- NCT number
- NCT05541471
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-22
- Primary completion
- 2023-04-16
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.